Source: Carcinogenesis. Unidade: FCF
Subjects: CARCINOGÊNESE ANIMAL, NEOPLASIAS (QUIMIOTERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DE CONTI, Aline et al. The chemopreventive activity of the butyric acid prodrug tributyrin in experimental rat hepatocarcinogenesis is associated with p53 acetylation and activation of the p53 apoptotic signaling pathway. Carcinogenesis, v. 34, n. 8, p. 1900-1906, 2013Tradução . . Disponível em: https://doi.org/10.1093/carcin/bgt124. Acesso em: 19 abr. 2024.APA
De Conti, A., Tryndyak, V., Koturbash, I., Heidor, R., Kuroiwa-Trzmielina, J., Ong, T. P., et al. (2013). The chemopreventive activity of the butyric acid prodrug tributyrin in experimental rat hepatocarcinogenesis is associated with p53 acetylation and activation of the p53 apoptotic signaling pathway. Carcinogenesis, 34( 8), 1900-1906. doi:10.1093/carcin/bgt124NLM
De Conti A, Tryndyak V, Koturbash I, Heidor R, Kuroiwa-Trzmielina J, Ong TP, Beland FA, Moreno FS, Pogribny IP. The chemopreventive activity of the butyric acid prodrug tributyrin in experimental rat hepatocarcinogenesis is associated with p53 acetylation and activation of the p53 apoptotic signaling pathway [Internet]. Carcinogenesis. 2013 ; 34( 8): 1900-1906.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1093/carcin/bgt124Vancouver
De Conti A, Tryndyak V, Koturbash I, Heidor R, Kuroiwa-Trzmielina J, Ong TP, Beland FA, Moreno FS, Pogribny IP. The chemopreventive activity of the butyric acid prodrug tributyrin in experimental rat hepatocarcinogenesis is associated with p53 acetylation and activation of the p53 apoptotic signaling pathway [Internet]. Carcinogenesis. 2013 ; 34( 8): 1900-1906.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1093/carcin/bgt124